- Report
- January 2022
- 200 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Myfortic is a brand of immune disorder drugs used to treat a variety of conditions, including Crohn's disease, ulcerative colitis, and lupus. It is a type of immunosuppressant, meaning it works by suppressing the body's immune system to reduce inflammation and other symptoms. Myfortic is typically taken orally in the form of a tablet or capsule. It is also available as an intravenous injection.
Myfortic is used to reduce the risk of organ rejection in patients who have had a kidney transplant. It is also used to treat rheumatoid arthritis, psoriasis, and other autoimmune diseases. It is often prescribed in combination with other medications to maximize its effectiveness.
The Myfortic market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novartis, Pfizer, Merck, and AbbVie. Other companies include AstraZeneca, Sanofi, and Bristol-Myers Squibb. Show Less Read more